{"id":3768,"date":"2021-05-20T17:45:00","date_gmt":"2021-05-20T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual-2\/"},"modified":"2024-08-02T12:42:30","modified_gmt":"2024-08-02T10:42:30","slug":"mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual-2","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual-2\/","title":{"rendered":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122"},"content":{"rendered":"

Further validation of how the use of Cellvizio potentially impacts patient management and improves outcomes in multiple gastrointestinal indications <\/i><\/b><\/p>\n

Mauna Kea Technologies today announced the presentation of 7 abstracts supporting Cellvizio®<\/sup> at Digestive Disease Week®<\/sup> (DDW) 2021 Virtual™, being held May 21-23. These abstracts focus on Barrett’s esophagus (BE), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and associated food allergies, pancreatic cysts and other gastrointestinal diseases. Studies are focused on how the use of Cellvizio potentially impacts patient management and improves outcomes. <\/p>\n

“Real-time in vivo <\/i>cellular imaging with Cellvizio is once again taking center stage at Digestive Disease Week as evidenced by the many high-quality studies presented this year,” said Robert L. Gershon, Chief Executive Officer of Mauna Kea Technologies. “We are excited to see the number and range of studies being presented and discussed, supporting how the use of Cellvizio potentially impacts patient management and improves outcomes in Barrett’s esophagus, pancreatic cysts, and inflammatory bowel disease applications, and highlighting the important new role Cellvizio could play in the management of patients suffering from irritable bowel syndrome, a chronic functional disorder of the gastrointestinal system affecting approximately 9.2% of the global population1<\/sup>.” <\/p>\n

Highlighted featured presentations (in chronological order): <\/b><\/p>\n

CONFOCAL LASER ENDOMICROSCOPY IN THE COLONIC MUCOSA OF PATIENTS WITH DIVERTICULAR DISEASE: INTERIM RESULTS <\/b><\/a>
\nPresentation #156 
\nFriday, May 21 from 1:47 – 1:53 p.m. ET 
\nPresenting Author: Miguel Puga-Tejada, Instituto Ecuatoriano de Enfermedades Digestiva, Ecuador <\/p>\n

ACCURACY AND AGREEMENT OF AN INTERNATIONAL PANEL FOR THE DIAGNOSIS OF PANCREATIC CYSTIC LESIONS USING EUS-GUIDED NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY <\/b><\/a>
\nPresentation #78 
\nFriday, May 21 from 2:02 – 2:16 p.m. ET 
\nPresenting Author: Jorge Machicado, Mayo Clinic Health System, Eau Claire, Wisconsin, United States <\/p>\n

CONFOCAL LASER ENDOMICROSCOPY IN COMBINATION WITH MOLECULAR BIOMARKERS FOR THE DIAGNOSIS OF INCONSPICUOUS DYSPLASIA IN BARRETT'S ESOPHAGUS: A RANDOMISED CROSS-OVER TRIAL <\/b><\/a>
\nPresentation #227 
\nFriday, May 21 from 1:47 – 1:53 p.m. ET 
\nPresenting Author: Mathew Vithayathil, MRC Cancer Unit, University of Cambridge, Redhill, United Kingdom <\/p>\n

FOOD ALLERGY SENSITIVITY TEST (FAST) WITH ENDOMICROSCOPY OF THE DUODENUM ENABLES TAILORED EXCLUSION DIET IN PATIENTS WITH IRRITABLE BOWEL SYNDROM<\/b><\/a>
\nPresentation #819 
\nSunday, May 23 from 4:08 – 4:16 p.m. ET 
\nPresenting Author: Ralf Kiesslich, HELIOS Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Hessen, Germany <\/p>\n

Featured poster sessions (in chronological order): <\/b><\/p>\n

RESPONSE TO BIOLOGICS IN IBD PATIENTS ASSESSED BY COMPUTERIZED IMAGE ANALYSIS OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY WITH MOLECULAR LABELING<\/a> <\/b>
\nPoster #Fr596 
\nFriday, May 21 from 12:15 – 1:00 p.m. ET 
\nPresenting Author: Marietta Iacucci<\/i>, Institute Translational of Medicine, Institute of Immunology and Immunotherapy and NIHR Birmingham Biomedical Research Centre, University Hospitals NHS Foundation Trust and University of Birmingham, Birmingham, UK, Birmingham, United Kingdom <\/p>\n

PROBE BASED CONFOCAL ENDOMICROSCOPY MAY INCREASE DETECTION OF LOW GRADE DYSPLASIA IN MALE VETERANS PREVIOUSLY DIAGNOSED WITH NON DYSPLASTIC SHORT SEGMENT BARRETT'S ESOPHAGUS UNDERGOING SURVEILLANCE <\/b><\/a>
\nPoster #Fr223 
\nFriday, May 21 from 12:15 – 1:00 p.m. ET 
\nPresenting Author: Karen Chang, University of California System, Oakland, California, United States <\/p>\n

DEVELOPMENT OF CONFOCAL ENDOMICROSCOPY CRITERIA FOR EARLY SIGNET-RING CELL CARCINOMA IN PATIENTS WITH HEREDITARY DIFFUSE GASTRIC CANCER SYNDROME <\/b><\/a>
\nPoster # Su585 
\nSunday, May 23 from 12:15 – 1:00 p.m. ET 
\nPresenting Author: Nastazja Dagny Pilonis, Department of Gastroenterological Oncology, Maria-Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland, Warsaw, Poland; MRC Cancer Unit, Cambridge, United Kingdom <\/p>\n

Visitors are invited to visit our DDW 2021 virtual page: <\/b>https:\/\/www.landing.maunakeatech.com\/en\/ddw-2021 <\/b><\/a><\/p>\n

\n

1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016\/S2468-1253(20)30217-X. Epub 2020 Jul 20. Erratum in: Lancet Gastroenterol Hepatol. 2020 Dec;5(12):e8. PMID: 32702295.  <\/span><\/p>\n

<\/p>\n

READ THE COMPLETE PRESS RELEASE<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Further validation of how the use of Cellvizio potentially impacts patient management and improves outcomes in multiple gastrointestinal indications  Mauna Kea Technologies today announced the presentation of 7 abstracts supporting Cellvizio® at Digestive Disease Week® (DDW) 2021 Virtual™, being held May 21-23. These abstracts focus on Barrett’s esophagus (BE), inflammatory bowel disease (IBD), irritable bowel syndrome […]<\/p>\n","protected":false},"author":6,"featured_media":3769,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34],"tags":[],"class_list":["post-3768","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-int"],"yoast_head":"\nMauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Further validation of how the use of Cellvizio potentially impacts patient management and improves outcomes in multiple gastrointestinal indications  Mauna Kea Technologies today announced the presentation of 7 abstracts supporting Cellvizio® at Digestive Disease Week® (DDW) 2021 Virtual™, being held May 21-23. These abstracts focus on Barrett’s esophagus (BE), inflammatory bowel disease (IBD), irritable bowel syndrome […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T15:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-02T10:42:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Zina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\"},\"author\":{\"name\":\"Zina\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"headline\":\"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122\",\"datePublished\":\"2021-05-20T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:42:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\"},\"wordCount\":658,\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"int\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\",\"url\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\",\"name\":\"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"datePublished\":\"2021-05-20T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:42:30+00:00\",\"author\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#breadcrumb\"},\"inLanguage\":\"int\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage\",\"url\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"contentUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.maunakeatech.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.maunakeatech.com\/#website\",\"url\":\"https:\/\/www.maunakeatech.com\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.maunakeatech.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"int\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac\",\"name\":\"Zina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"caption\":\"Zina\"},\"url\":\"https:\/\/www.maunakeatech.com\/int\/author\/zina\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/","og_locale":"en_US","og_type":"article","og_title":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies","og_description":"Further validation of how the use of Cellvizio potentially impacts patient management and improves outcomes in multiple gastrointestinal indications  Mauna Kea Technologies today announced the presentation of 7 abstracts supporting Cellvizio® at Digestive Disease Week® (DDW) 2021 Virtual™, being held May 21-23. These abstracts focus on Barrett’s esophagus (BE), inflammatory bowel disease (IBD), irritable bowel syndrome […]","og_url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2021-05-20T15:45:00+00:00","article_modified_time":"2024-08-02T10:42:30+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","type":"image\/png"}],"author":"Zina","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"Written by":"Zina","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/"},"author":{"name":"Zina","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"headline":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122","datePublished":"2021-05-20T15:45:00+00:00","dateModified":"2024-08-02T10:42:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/"},"wordCount":658,"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","articleSection":["News"],"inLanguage":"int"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/","url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/","name":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122 - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","datePublished":"2021-05-20T15:45:00+00:00","dateModified":"2024-08-02T10:42:30+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#breadcrumb"},"inLanguage":"int","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/"]}]},{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-7-presentations-highlighting-the-clinical-value-of-cellvizio-in-gastrointestinal-diseases-at-digestive-disease-week-ddw-2021-virtual\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies Announces 7 Presentations Highlighting the Clinical Value of Cellvizio\u00ae in Gastrointestinal Diseases at Digestive Disease Week\u00ae (DDW) 2021 Virtual\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"int"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac","name":"Zina","image":{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","caption":"Zina"},"url":"https:\/\/www.maunakeatech.com\/int\/author\/zina\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/comments?post=3768"}],"version-history":[{"count":1,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3768\/revisions"}],"predecessor-version":[{"id":5561,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3768\/revisions\/5561"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media\/3769"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media?parent=3768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/categories?post=3768"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/tags?post=3768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}